JTJ. Baptist Trimbos

J. Baptist Trimbos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


J. Baptist Trimbos has a total of 71 co-authors. Here are the top co-authors by number of shared publications:

  • Petra Timmers

    Affiliations of authors: Department of Gynecology, Leiden University Medical Center, Leiden, the Netherlands (BT); Medisch Centrum Rijnmond Zuid, Rotterdam, the Netherlands (PT); EORTC Data Centre, Brussels, Belgium (PT, CC, KV, AC); Department of Obstetrics and Gynaecology, University of Brescia, Brescia, Italy (SP); Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands (MvdB); Department of Medical Oncology, Hospital Universitario San Carlos, Madrid, Spain (AC)

    3 shared publications
  • A. A. W. Peters

    Department of Gynecology, Leiden University Medical Center, Leiden, the Netherlands

    2 shared publications
  • C. P. Maas

    Department of Gynecology, Leiden University Medical Center, Leiden, the Netherlands

    2 shared publications
  • Caroline van Haaften

    Department of Gynecology, Leiden University Medical Center, Leiden, the Netherlands

    2 shared publications
  • Constantino Mangioni

    2 shared publications
  • Corneel Coens

    Affiliations of authors: Department of Gynecology, Leiden University Medical Center, Leiden, the Netherlands (BT); Medisch Centrum Rijnmond Zuid, Rotterdam, the Netherlands (PT); EORTC Data Centre, Brussels, Belgium (PT, CC, KV, AC); Department of Obstetrics and Gynaecology, University of Brescia, Brescia, Italy (SP); Department of Medical Oncology, Erasmus Medical Center, Rotterdam, the Netherlands (MvdB); Department of Medical Oncology, Hospital Universitario San Carlos, Madrid, Spain (AC)

    2 shared publications

Latest Publications

  • Open Access

    Morphological and phenotypical features of ovarian metastases in breast cancer patients

    by Inge T. A. Peters, Merle A. van der Steen, Bertine W. Huisman, Carina G. J .M. Hilders, Vincent T. H. B. M. Smit, Alexander L. Vahrmeijer, Cornelis F. M. Sier, J. Baptist Trimbos, Peter J. K. Kuppen

    Autotransplantation of frozen-thawed ovarian tissue is a method to preserve ovarian function and fertility in patients undergoing gonadotoxic therapy. In oncology patients, the safety cannot yet be guaranteed, since current tumor detection methods can only exclude the presence of malignant cells in ovarian fragments that are not transplanted. We determined the need for a novel detection method by studying the distribution of tumor cells in ovaries from patients with breast cancer. Furthermore, we examined which cell-surface proteins are suitable as a target for non-invasive tumor-specific imaging of ovarian metastases from invasive breast cancer. Using the nationwide database of the Dutch Pathology Registry (PALGA), we identified a cohort of 46 women with primary invasive breast cancer and ovarian metastases. The localization and morphology of ovarian metastases were determined on hematoxylin-and-eosin-stained sections. The following cell-surface markers were immunohistochemically analyzed: E-cadherin, epithelial membrane antigen (EMA), human epidermal growth receptor type 2 (Her2/neu), carcinoembryonic antigen (CEA), αvβ6 integrin and epithelial cell adhesion molecule (EpCAM). The majority of ovarian metastases (71%) consisted of a solitary metastasis or multiple distinct nodules separated by uninvolved ovarian tissue, suggesting that ovarian metastases might be overlooked by the current detection approach. Combining the targets E-cadherin, EMA and Her2/neu resulted in nearly 100% detection of ductal ovarian metastases, whereas the combination of EMA, Her2/neu and EpCAM was most suitable to detect lobular ovarian metastases. Examination of the actual ovarian transplants is recommended. A combination of targets is most appropriate to detect ovarian metastases by tumor-specific imaging.


  • Open Access

    The effect of a dopamine antagonist on conditioning of sexual arousal in women

    by Mirte Brom, Ellen Laan, Walter Everaerd, Philip Spinhoven, Baptist Trimbos, Stephanie Both

    Rationale Dopamine (DA) plays a key role in reward-seeking behaviours. Accumulating evidence from animal and human studies suggests that human sexual reward learning may also depend on DA transmission. However, research on the role of DA in human sexual reward learning is completely lacking. Objectives To investigate whether DA antagonism attenuates classical conditioning of sexual response in humans. Methods Healthy women were randomly allocated to one of two treatment conditions: haloperidol (n = 29) or placebo (n = 29). A differential conditioning paradigm was applied with genital vibrostimulation as unconditional stimulus (US) and neutral pictures as conditional stimuli (CSs). Genital arousal was assessed, and ratings of affective value and subjective sexual arousal were obtained. Results Haloperidol administration affected unconditional genital responding. However, no significant effects of medication were found for conditioned responding. Conclusions No firm conclusions can be drawn about whether female sexual reward learning implicates DA transmission since the results do not lend themselves to unambiguous interpretation.


  • d -Cycloserine reduces context specificity of sexual extinction learning

    by Mirte Brom, Ellen Laan, Walter Everaerd, Philip Spinhoven, Baptist Trimbos, Stephanie Both


  • Open Access

    Synergistic effects of the sesquiterpene lactone, EPD, with cisplatin and paclitaxel in ovarian cancer cells

    by Caroline van Haaften, Arnoud Boot, Willem E Corver, Jaap Dh van Eendenburg, Baptist Jmz Trimbos, Tom van Wezel

    Ovarian cancer remains still the leading cause of death of gynecological malignancy, in spite of first-line chemotherapy with cisplatin and paclitaxel. Although initial response is favorably, relapses are common and prognosis for women with advanced disease stays poor. Therefore efficacious approaches are needed. Previously, an anti-cancer agent, EPD exhibited potent cytotoxic effects towards ovarian cancer and not towards normal cells. Cell viability and cell cycle analysis studies were performed with EPD, in combination with cisplatin and/or paclitaxel, using the ovarian carcinoma cell lines: SK-OV-3, OVCAR-3, JC, JC-pl and normal fibroblasts. Cell viability was measured using Presto Blue and cell cycle analysis using a flow cytometer. Apoptosis was measured in JC and JC-pl , using the caspase 3 assay kit. In JC-pl, SK-OV-3 and JC, synergistic interactions between either EPD and cisplatin or EPD and paclitaxel were observed. For the first time the effects of EPD on the cell cycle of ovarian cancer cells and normal cells was studied. EPD and combinations of EPD with cisplatin and/ or paclitaxel showed cell cycle arrest in the G2/M phase. The combination of EPD and cisplatin showed a significant synergistic effect in cell line JC-pl, while EPD with paclitaxel showed synergistic interaction in JC. Additionally, synergistic drug combinations showed increased apoptosis. Our results showed a synergistic effect of EPD and cisplatin in an ovarian drug resistant cell line as well as a synergistic effect of EPD and paclitaxel in two other ovarian cell lines. These results might enhance clinical efficacy, compared to the existing regimen of paclitaxel and cisplatin.


  • Open Access

    Strength of sliding knots in multifilament resorbable suture materials

    by Nourah van Leeuwen, J. Baptist Trimbos

    Experimental laboratory study was made to test the knot integrity of identical, non-identical and parallel sliding knots, with three and five throws, made with synthetic resorbable multifilament suture materials. The knots were made with Novosyn (polyglactin 612), Safil (polyglycolic acid), Vicryl (polyglactin 612) and Vicryl plus (polyglactin 910 + triclosan), all with suture size: 3-0 USP. Per material 10 knots for every kind of knot were tested in a tensiometer, resulting in a total of 240 tests. Sliding knots with three throws were compared with the five throw sliding knots, and a comparison of the loop-holding capacities (LHC) of the different suture materials was made. Differences in suture material, knot type, and number of throws in the knot had a remarkable effect on knot performance. Adding two extra throws to a three throw non-identical or parallel sliding knot resulted in significantly more reliable knots (P < 0.05). In identical sliding knots, this effect was not seen, but these knots showed low LHCs, indicating poor knot reliability. Compared to the other suture materials, Safil showed significantly lower LHCs. Most of the mean LHCs of the various knots with Vicryl, Vicryl Plus or Novosyn were not statistically different from each other. Identical sliding knots appeared to be very unreliable, especially when made with three throws. Non-identical and parallel slipknots with five throws demonstrated superior knot integrity compared with the same knot types with three throws. Safil had inferior knot properties as compared to the other materials, but Vicryl, Vicryl Plus and Novosyn behaved virtually the same. The type of knot and the use of different suture materials have important influence on the integrity of the knot. A high knot reliability is nowadays all the more important because of the frequent use of resorbable suture materials. The suture gradually loses strength during the resorption process, so that an extra margin of safety neutralizes the effect of this process.


  • Lymphadenectomy in ovarian cancer

    by J. Baptist Trimbos

    The clinical significance of lymphadenectomy in ovarian cancer is controversial. In early ovarian cancer (EOC), it is the extent of the procedure that is the main focus of debate. In advanced disease [advanced ovarian cancer (AOC)], the issue is whether or not lymphadenectomy independently impacts survival. This review summarizes the current standard of care as it relates to the role of lymphadenectomy in ovarian cancer. Lymphadenectomy in EOC is a diagnostic procedure in as much as it is an integral and mandatory part of a complete surgical staging. The required extent of the procedure, however, remains uncertain. It has been suggested that at least 10 nodes from different, predefined retroperitoneal sites should be the minimum number removed. Lymphadenectomy in AOC is of potential therapeutic value. The only published randomized clinical trial (RCT) showed no overall survival benefit after radical/systematic lymphadenectomy, although there was an impact on 6-month disease-free survival. Conversely, retrospective studies, a meta-analysis and a re-analysis of three RCTs in AOC do suggest an overall survival benefit for radical/systematic lymphadenectomy. This review concludes with the recommendation that lymphadenectomy in EOC is a mandatory part of surgical staging and that a minimum of 10 nodes should be harvested from different retroperitoneal sites. In AOC, lymphadenectomy can be considered when intraperitoneal cytoreduction has been complete or when there are bulky nodes.


  • Open Access

    Potent cytotoxic effects of Calomeria amaranthoides on ovarian cancers

    by Caroline van Haaften, Colin C Duke, Arij M Weerheim, Nico Pm Smit, Paul Mm van Haard, Firouz Darroudi, Baptist Jmz Trimbos

    Ovarian cancer remains the leading cause of death from gynaecological malignancy. More than 60% of the patients are presenting the disease in stage III or IV. In spite of combination of chemotherapy and surgery the prognosis stays poor for therapy regimen.


  • Open Access

    Surgical Staging and Treatment of Early Ovarian Cancer: Long-term Analysis From a Randomized Trial

    by Baptist Trimbos, Petra Timmers, Sergio Pecorelli, Corneel Coens, Koen Ven, Maria van der Burg, Antonio Casado

    A long-term follow-up analysis of the randomized clinical trial Adjuvant Chemotherapy in Ovarian Neoplasm (ACTION) from the European Organization for Research and Treatment of Cancer was undertaken to determine whether the original results with a median follow-up of 5.5 years could be verified after longer follow-up with more events. In the ACTION trial, 448 patients with early ovarian cancer were randomly assigned, after surgery, to adjuvant chemotherapy or to observation (no further treatment). The original analysis found that adjuvant chemotherapy improved recurrence-free survival but not overall survival and found in a subgroup analysis that completeness of surgical staging was an independent prognostic factor, with better recurrence-free and overall survival among those with complete (optimal) surgical staging. After a median follow-up of 10.1 years, we analyzed the more mature data from the ACTION trial and found support for most of the main conclusions of the original analysis, except that overall survival after optimal surgical staging was improved, even among patients who received adjuvant chemotherapy (hazard ratio of death = 1.89, 95% confidence interval = 0.99 to 3.60; overall two-sided log-rank test P = .05). More cancer-specific deaths were observed among nonoptimally staged patients (40 [27%] of the 147 deaths in the observation arm and 11 [14%] of the 76 deaths in the adjuvant chemotherapy arm) than among optimally staged patients (seven [9%] of the 75 deaths in the observation arm and 11 [14%] of the 76 deaths in the adjuvant chemotherapy arm) (two-sided χ 2 test for heterogeneity, P = .06). Thus, completeness of surgical staging in patients with early ovarian cancer was found to be statistically significantly associated with better outcomes, and the benefit from adjuvant chemotherapy appeared to be restricted to patients with nonoptimal surgical staging.


  • Open Access

    The Swift operation: a modification of the Leiden nerve-sparing radical hysterectomy

    by J. B. Trimbos, S. A. H. M. van Den Tillaart, C. P. Maas, A. A. W. Peters, K. N. Gaarenstroom, M. C. DeRuiter, G. G. Kenter


  • Prognostic difference of surgical treatment of exophytic versus barrel-shaped bulky cervical cancer

    by J.B. Trimbos, A.F. Lambeek, A.A.W. Peters, R. Wolterbeek, K.N. Gaarenstroom, G.J. Fleuren, G.G. Kenter